Operating Lease, Right-of-Use Asset of Esperion Therapeutics, Inc. from 31 Mar 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Esperion Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Mar 2019 to 30 Sep 2025.
  • Esperion Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $3,325,000, a 47% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Esperion Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $3,325,000 -$2,897,000 -47% 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 $4,233,000 -$2,615,000 -38% 30 Jun 2025 10-Q 13 Aug 2025 2025 Q2
Q1 2025 $4,967,000 -$2,163,000 -30% 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 $5,513,000 +$838,000 +18% 31 Dec 2024 10-Q 06 Nov 2025 2025 Q3
Q3 2024 $6,222,000 +$3,206,000 +106% 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 $6,848,000 +$4,435,000 +184% 30 Jun 2024 10-Q 12 Aug 2024 2024 Q2
Q1 2024 $7,130,000 +$6,055,000 +563% 31 Mar 2024 10-Q 07 May 2024 2024 Q1
Q4 2023 $4,675,000 +$3,639,000 +351% 31 Dec 2023 10-K 07 Mar 2025 2024 FY
Q3 2023 $3,016,000 +$2,286,000 +313% 30 Sep 2023 10-Q 07 Nov 2023 2023 Q3
Q2 2023 $2,413,000 +$1,328,000 +122% 30 Jun 2023 10-Q 01 Aug 2023 2023 Q2
Q1 2023 $1,075,000 -$392,000 -27% 31 Mar 2023 10-Q 09 May 2023 2023 Q1
Q4 2022 $1,036,000 -$862,000 -45% 31 Dec 2022 10-K 27 Feb 2024 2023 FY
Q3 2022 $730,000 -$2,985,000 -80% 30 Sep 2022 10-Q 01 Nov 2022 2022 Q3
Q2 2022 $1,085,000 -$3,176,000 -75% 30 Jun 2022 10-Q 02 Aug 2022 2022 Q2
Q1 2022 $1,467,000 -$3,385,000 -70% 31 Mar 2022 10-Q 03 May 2022 2022 Q1
Q4 2021 $1,898,000 -$4,132,000 -69% 31 Dec 2021 10-K 21 Feb 2023 2022 FY
Q3 2021 $3,715,000 -$2,987,000 -45% 30 Sep 2021 10-Q 02 Nov 2021 2021 Q3
Q2 2021 $4,261,000 -$1,914,000 -31% 30 Jun 2021 10-Q 03 Aug 2021 2021 Q2
Q1 2021 $4,852,000 -$658,000 -12% 31 Mar 2021 10-Q 04 May 2021 2021 Q1
Q4 2020 $6,030,000 +$4,498,000 +294% 31 Dec 2020 10-K 22 Feb 2022 2021 FY
Q3 2020 $6,702,000 +$5,646,000 +535% 30 Sep 2020 10-Q 02 Nov 2020 2020 Q3
Q2 2020 $6,175,000 +$5,243,000 +563% 30 Jun 2020 10-Q 10 Aug 2020 2020 Q2
Q1 2020 $5,510,000 +$4,559,000 +479% 31 Mar 2020 10-Q 06 May 2020 2020 Q1
Q4 2019 $1,532,000 31 Dec 2019 10-K 23 Feb 2021 2020 FY
Q3 2019 $1,056,000 30 Sep 2019 10-Q 06 Nov 2019 2019 Q3
Q2 2019 $932,000 30 Jun 2019 10-Q 08 Aug 2019 2019 Q2
Q1 2019 $951,000 31 Mar 2019 10-Q 08 May 2019 2019 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.